Culagbang, Rhea B.

HRN: 05-79-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/30/2022
07/07/2022
IV
88mg
Q8
Infected Retained Placenta And Unrepaired Episiotomy
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: